3
Authors
11
References
2019
Year Published
Abstract
Odontogenic keratocyst is one of the most aggressive odontogenic cysts arising from odontogenic epithelium. It can become quite large because of its ability for significant expansion, extension into adjacent tissues and rapid growth. Thus they are often locally destructive and tend to recur. The goals of treatment should eliminate the potential recurrence and minimize the surgical morbidity.
KEYWORDS: Keratocystic odontogenic tumor, Odontogenic keratocyst, Basal nevus syndrome, Marsupialization, Vismodegib
How to Cite
Godwin Alex Kiruba J, Devadoss P, Ravi N. Odontogenic Keratocyst – Recent Updates In Management. J Indian Dent Assoc Madras. 2019;6(4):154-157. DOI: 10.37841/jidam_2019_V6_I4_07
Godwin Alex Kiruba, J., Devadoss, P., & Ravi, N. (2019). Odontogenic Keratocyst – Recent Updates In Management. Journal of Indian Dental Association Madras, 6(4), 154-157. https://doi.org/10.37841/jidam_2019_V6_I4_07
Godwin Alex Kiruba, J., Pradeep Devadoss, and Nikita Ravi. "Odontogenic Keratocyst – Recent Updates In Management." Journal of Indian Dental Association Madras, vol. 6, no. 4, 2019, pp. 154-157. DOI: 10.37841/jidam_2019_V6_I4_07.
Godwin Alex Kiruba J, Devadoss P, Ravi N. Odontogenic Keratocyst – Recent Updates In Management. J Indian Dent Assoc Madras. 2019;6(4):154-157. doi:10.37841/jidam_2019_V6_I4_07
Godwin Alex Kiruba, J., Pradeep Devadoss, and Nikita Ravi. "Odontogenic Keratocyst – Recent Updates In Management." Journal of Indian Dental Association Madras 6, no. 4 (2019): 154-157. https://doi.org/10.37841/jidam_2019_V6_I4_07.
References
- Pogrel A. The history of the odontogenic keratocyst. Oral Maxillofacial Surg Clin N Am. 2003; 15:311–315.
- Scully C, Langdon J, Evans J. Marathon of eponyms; 7 Gorlin-Goltz syndrome (naevoid basal cell carcinoma syndrome). Oral Dis 2010; 16:117–118.
- Pogrel A. The keratocystic odontogenic tumour. Oral Maxillofacial Surg Clin N Am. 2013; 25:21–30.
- Voorsmit RA, Stoelinga PJ, van Haelst UJ (1981) The management of keratocysts. J Maxillofac Surg. 9:228–236
- Silva YS, Stoelinga PJ, Naclério-Homem MG. The presentation of odontogenic keratocysts in the jaws with an emphasis on the tooth-bearing area: a systematic review and meta-analysis. Oral Maxillofacial Surg. 2019; 1-5.
- Bell RB, Dierks EJ. Treatment options for the recurrent odontogenic keratocyst. Oral Maxillofacial Surg Clin N Am. 2003; 15:429–446.
- Belgal PG, Pathak B, Shastry L. Updates in the surgical management of odontogenic keratocyst. J Advanced Clin Res Insights. 2019; 6:116–118.
- Ledderhof NJ, Caminiti MF, Bradley G, Lam DK, Topical 5-Fluorouracil is a Novel Targeted Therapy for the Keratocystic Odontogenic Tumor, J Oral Maxillofac Surg. 2017; 75(3):514-524.
- Aditya S, Rattan A. Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma. Ind derm online journal. 2013; 4(4):365- 369.
- Ally MS, Tang JY, Joseph T, Thompson B, Lindgren J, Raphael MA, Ulerio G, Chanana AM, MackayWiggan JM, Bickers DR, Epstein EH. The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome. JAMA dermatology. 2014;150(5):542-545.
- Jain S, Song R, Xie J. Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas. Onco Targets and therapy. 2017; 10:1645-1653.